These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2179570)

  • 1. Lymphocytes stimulated with recombinant human interleukin-2: relationship between motility into protein matrix and in vivo localization in normal and neoplastic tissues of mice.
    Ratner S
    J Natl Cancer Inst; 1990 Apr; 82(7):612-6. PubMed ID: 2179570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility of IL-2-stimulated lymphocytes in neutral and acidified extracellular matrix.
    Ratner S
    Cell Immunol; 1992 Feb; 139(2):399-410. PubMed ID: 1733511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte development of adherence and motility in extracellular matrix during IL-2 stimulation.
    Ratner S; Patrick P; Bora G
    J Immunol; 1992 Jul; 149(2):681-8. PubMed ID: 1385607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motility and tumoricidal activity of interleukin-2-stimulated lymphocytes.
    Ratner S; Heppner GH
    Cancer Res; 1988 Jun; 48(12):3374-80. PubMed ID: 2453269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characteristics of intraepithelial lymphocytes from mouse small intestine. III. Inability of intraepithelial lymphocytes to induce a systemic graft-versus-host reaction is because of failure to migrate in vivo.
    Baca ME; Mowat AM; MacKenzie S; Parrott DM
    Gut; 1987 Oct; 28(10):1267-74. PubMed ID: 3500097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motility of murine lymphocytes during transit through cell cycle. Analysis by a new in vitro assay.
    Ratner S; Jasti RK; Heppner GH
    J Immunol; 1988 Jan; 140(2):583-8. PubMed ID: 3335783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic aspects of fibrosis in mouse mammary carcinomas.
    Vaage J
    Int J Cancer; 1992 Jan; 50(1):69-74. PubMed ID: 1728615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes.
    Applegate KG; Balch CM; Pellis NR
    Cancer Res; 1990 Nov; 50(22):7153-8. PubMed ID: 2224850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.
    Spiess PJ; Yang JC; Rosenberg SA
    J Natl Cancer Inst; 1987 Nov; 79(5):1067-75. PubMed ID: 3500355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of spontaneous murine breast tumors by human interleukin 2-stimulated syngeneic T-lymphocytes.
    Merluzzi VJ; Savage DM; Souza L; Boone T; Mertelsmann R; Welte K; Last-Barney K
    Cancer Res; 1985 Jan; 45(1):203-6. PubMed ID: 3871172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of T cell localization in mammary tumors through transient inhibition of T cell myosin function.
    Ratner S; Wei WZ; Oliver J; Oliver J
    Cell Immunol; 2005 Jan; 233(1):1-10. PubMed ID: 15936742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice.
    Wong MW; Chew BP; Wong TS; Hosick HL; Boylston TD; Shultz TD
    Anticancer Res; 1997; 17(2A):987-93. PubMed ID: 9137439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.
    Yoo YK; Heo DS; Hata K; Van Thiel DH; Whiteside TL
    Gastroenterology; 1990 Feb; 98(2):259-68. PubMed ID: 2295382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.
    Blazar BA; Laing CA; Miller FR; Heppner GH
    J Natl Cancer Inst; 1980 Aug; 65(2):405-10. PubMed ID: 6931258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.
    Cavallo F; Giovarelli M; Gulino A; Vacca A; Stoppacciaro A; Modesti A; Forni G
    J Immunol; 1992 Dec; 149(11):3627-35. PubMed ID: 1358974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes.
    Salup RR; Toth JA; Hiserodt JC; Wolmark N
    Prog Clin Biol Res; 1987; 244():39-48. PubMed ID: 2958875
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.